Khakoo S,Glue P, Grellier L, Wells B, Bell A, Dash C, Murray-Lyon I, Lypnyj D, FlanneryB, Walters K, Dusheiko GM. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol (1998) 46, 563–70.
Glue P,Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S, Clement RP. Adose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. TheHepatitis C Intervention Therapy Group. Hepatology (2000) 32, 647–53.